3 minDostarlimab receives approval as a revolutionary treatment in endometrial cancerEndometrial cancer, the most prevalent uterine cancer subtype, is the fourth most common cancer among women worldwide.
4 minOvercoming the challenges of low PD-L1 lung cancer: The latest immunotherapy regimenThe addition of immune checkpoint inhibitors to lung cancer treatment has shown promising outcomes in terms of increasing survival rates.
4 minImmunotherapy for the treatment of diffuse intrinsic pontine glioma: a paradigm-shift in opportunityBrainstem glioma is a heterogeneous group of tumors that comprise diffuse intrinsic pontine glioma (DIPG), glioblastoma, etc.